“…Although the technical safety and efficacy of atheroablative and thrombectomy devices have been described, few data exist to demonstrate incremental benefit with regard to clinical outcomes, and even less information is available that describes the use of these strategies specifically in patients with UA/NSTEMI. 587 The need to continue with the development of safer, more effective PCI techniques is emphasized by recently raised concerns about delayed endothelialization over DES and consequent increases in late coronary thrombotic events, potentially leading to death or MI. 399,400,402,403,411 Other techniques and devices, such as the AngioJet thrombectomy catheter, have been tested for the treatment of thrombi that are visible within a coronary artery.…”